Melioidosis Aortic Aneurysms, 2019-2025: Incidence, Management and Outcomes From a Regional Tertiary Centre in North

Oh Sung Choy1,2, David Sun1,2, Vimalin Vedanayagam1

  • 1Department of Vascular Surgery, Townsville University Hospital, Townsville, Queensland, Australia.

ANZ Journal of Surgery
|November 28, 2025
PubMed
Abstract

Insights

Melioidosis-associated aortic aneurysms are rare but dangerous surgical emergencies in endemic areas. Prompt diagnosis and treatment are crucial for improving patient outcomes and reducing high mortality risks.

Area of Science:

  • Vascular Surgery
  • Infectious Diseases
  • Medical Microbiology

Background:

  • Melioidosis, caused by Burkholderia pseudomallei, is an uncommon but severe cause of mycotic aortic aneurysms.
  • Endemic regions include North Queensland and Southeast Asia, posing significant health risks.

Purpose of the Study:

  • To describe the presentation, management, and outcomes of melioidosis-associated aortic aneurysms.
  • To evaluate the effectiveness of current treatment strategies in a regional tertiary center.

Main Methods:

  • Retrospective review of aortic aneurysm repairs (open and endovascular) from January 2019 to May 2025.
  • Collection of patient demographics, comorbidities, aneurysm characteristics, procedural details, and short-term/long-term outcomes.

Main Results:

  • Six out of 217 aortic aneurysm repairs (2.8%) were mycotic, with five yielding B. pseudomallei.
  • Four patients presented with emergency ruptures; aneurysm diameters ranged from 30-60mm.
  • Mortality rate was 40% (2/5 patients), with one early death and one late death from unrelated causes.

Conclusions:

  • Melioidosis aortic aneurysms in endemic regions typically present as surgical emergencies with high mortality.
  • Prompt imaging, microbiological diagnosis, and rapid surgical repair with antimicrobial therapy are essential.
  • Multicenter studies are needed to optimize long-term management and antibiotic protocols.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
650
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
589
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
478